PNTG:NSD-Pennant Group Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 21.57

Change

+0.17 (+0.79)%

Market Cap

USD 0.65B

Volume

0.19M

Analyst Target

USD 41.33
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-06 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
ENSG The Ensign Group Inc

N/A

USD 6.79B
ACHC Acadia Healthcare Company Inc

N/A

USD 6.16B
OPCH Option Care Health Inc

N/A

USD 5.24B
SGRY Surgery Partners Inc

N/A

USD 3.38B
AMED Amedisys Inc

N/A

USD 3.09B
LFST Lifestance Health Group Inc

N/A

USD 2.62B
ASTH Astrana Health Inc

N/A

USD 1.86B
AMEH Astrana Health Inc.

N/A

USD 1.86B
ADUS Addus HomeCare Corporation

N/A

USD 1.81B
HCSG Healthcare Services Group Inc

N/A

USD 0.82B

ETFs Containing PNTG

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 54.96% 90% A- 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 54.96% 90% A- 91% A-
Trailing 12 Months  
Capital Gain 83.57% 89% A- 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 83.57% 89% A- 92% A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.52% 61% D- 61% D-
Dividend Return 4.52% 61% D- 57% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 65.73% 32% F 25% F
Risk Adjusted Return 6.87% 64% D 47% F
Market Capitalization 0.65B 64% D 68% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.